Norepinephrine bitartrate
USP/1468501 - United States Pharmacopeia (USP) Reference Standard
Synonym: L-(−)-Norepinephrine (+)-bitartrate salt monohydrate; L-(−)-Noradrenaline (+)-bitartrate salt monohydrate
CAS Number: 108341-18-0
Empirical Formula (Hill Notation): C8H11NO3 · C4H6O6 · H2O
Molecular Weight: 337.28
MDL Number: MFCD00150449
Linear Formula: C8H11NO3 · C4H6O6 · H2O
Product Type: Chemical
API family | norepinephrine |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C8H11NO3.C4H6O6.H2O/c9 |
InChI key | LNBCGLZYLJMGKP-LUDZCAPTSA |
manufacturer/tradename | USP |
SMILES string | O.O[C@H]([C@@H](O)C(O)=O) |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | It is intended to be used as a USP reference standard in specified quality tests and assays. Also used to prepare standard and system suitability solutions as described in the following United States Pharmacopeia (USP) monographs:• Norepinephri • Norepinephrine Bitartrate Injection • Epinephrine • Racepinephrine • Epinephrine Bitartrate • Articaine Hydrochloride and Epinephrine Injection • Racepinephrine Hydrochloride |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H300 |
Precautionary statements | P301 + P330 + P331 + P310 |
RIDADR | UN 2811 6.1 / PGII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |